This company has been acquired
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Pardes Biosciences 관리
관리 기준 확인 1/4
Pardes Biosciences' CEO is Tom Wiggans, appointed in Mar 2022, has a tenure of 1.5 years. total yearly compensation is $5.26M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.082% of the company’s shares, worth $107.99K. The average tenure of the management team and the board of directors is 2.7 years and 2.4 years respectively.
주요 정보
Tom Wiggans
최고 경영자
US$5.3m
총 보상
| CEO 급여 비율 | 9.9% |
| CEO 임기 | 1.5yrs |
| CEO 소유권 | 0.08% |
| 경영진 평균 재임 기간 | 2.7yrs |
| 이사회 평균 재임 기간 | 2.4yrs |
최근 관리 업데이트
Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$521k | -US$97m |
보상 대 시장: Tom's total compensation ($USD5.26M) is above average for companies of similar size in the US market ($USD758.93K).
보상과 수익: Insufficient data to compare Tom's compensation with company performance.
CEO
Tom Wiggans (71 yo)
1.5yrs
테뉴어
US$5,255,958
보상
Mr. Thomas G. Wiggans, also known as Tom, serves as Independent Director at CymaBay Therapeutics, Inc. since April 2021. He serves as an Executive Chairman of Follica, Inc. since January 2021. He serves as...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | no data | US$3.52m | 9.35% $ 12.3m | |
| Chief Financial Officer | 2.7yrs | US$1.82m | 0.52% $ 684.2k | |
| General Counsel & Corporate Secretary | 2.7yrs | 데이터 없음 | 0.35% $ 456.1k |
2.7yrs
평균 재임 기간
56.5yo
평균 연령
경험이 풍부한 관리: PRDS's management team is considered experienced (2.7 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | 3.6yrs | US$3.52m | 9.35% $ 12.3m | |
| Director | 2.7yrs | US$110.69k | 데이터 없음 | |
| Independent Director | 2.7yrs | US$170.69k | 0.12% $ 152.0k | |
| Independent Director & Member of Scientific Advisory Board | 3.1yrs | US$153.69k | 0.12% $ 152.0k | |
| Independent Director | 2.7yrs | US$163.19k | 2.25% $ 2.9m | |
| Independent Director | less than a year | US$147.00k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$161.19k | 0% $ 0 | |
| Lead Independent Director | less than a year | US$146.94k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$153.69k | 0% $ 0 | |
| Member of Commercial Advisory Board | no data | 데이터 없음 | 데이터 없음 |
2.4yrs
평균 재임 기간
62.5yo
평균 연령
경험이 풍부한 이사회: PRDS's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.